Clinicopathological multiplicity of dementia with Lewy bodies

Neuropathology

Volumn 19, Issue 4, 1999, Pages 386-394

  Iseki, Eizo ^a   Marui, Wami ^a   Kosaka, Kenji ^a   Kato, Masanori ^b   Yamamoto, Takayuki ^c   Uéda, Kenji ^d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Soga Hospital   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer pathology; Clinicopathology; Dementia with Lewy bodies; Diagnostic criteria; Diffuse Lewy body disease; Immunohistochemistry; Lewy body

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN STEM; CELL LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; DEMENTIA; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; LIMBIC SYSTEM; MALE; NEOCORTEX; NERVE CELL; ONSET AGE; PARKINSONISM; PATHOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VISUAL HALLUCINATION;

EID: 0033378868     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.1999.00264.x     Document Type: Article

References (25)

1. Kosaka K. Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol Berl 1978; 42: 127-134.
2. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree. A new disease? Clin Neuropathol 1984; 3: 185-192.
3. Kosaka K, Iseki E, Odawara T, Yamamoto T. Cerebral type of Lewy body disease. Neuropathol 1996; 16: 32-35.
4. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197-204.
5. Byrne E, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiat 1989; 52: 709-717.
6. Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987; 110: 1131-1153.
7. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. J Neurol Sci 1990; 95: 119-139.
8. Hansen LA, Salmon D, Galasko D et al. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990; 40: 1-8.
9. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
10. Arima K, Ueda K, Sunohara N et al. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 1998; 808: 93-100.
11. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol Berl 1991; 82: 239-259.
12. Louis ED, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 1995; 10: 188-194.
13. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22: 911-922.
14. Kratka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996; 47: 1148-1152.
15. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiat 1989; 52: 67-71.
16. Rezaie P, Cairns NJ, Chadwick A, Lantos PL. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 1996; 212: 111-114.
17. Iseki E, Odawara T, Suzuki K, Kosaka K, Akiyama H, Ikeda K. A pathological study of Lewy bodies and senile changes in the amygdala in diffuse Lewy body disease. Neuropathol 1995; 15: 112-116.
18. Schmidt ML, Martin JA, Lee VM-Y, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol Berl 1997; 91: 475-481.
19. Iseki E, Marui W, Kosaka K, Uéda K. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 1999; 265: 9-12.
20. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997; 388: 839-840.
21. Uchihara T, Kondo K, Kosaka K, Tsukagoshi H. Selective loss of nigral neurons in Alzheimer's disease: a morphometric study. Acta Neuropathol Berl 1992; 83: 271-276.
22. Dickson DW, Ruan D, Crystal H et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease. Neurology 1991; 41: 1402-1409.
23. Iseki E, Li F, Odawara T, Kosaka K. Hippocampal pathology in diffuse Lewy body disease using ubiquitin-immunohistochemistry. J Neurol Sci 1997; 149: 165-169.
24. Hansen LA, Masliah E, Terry RD, Mirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol Berl 1989; 78: 194-201.
25. Iseki E, Li F, Kosaka K. Close relationship between spongiform change and ubiquitin-positive granular structures in diffuse Lewy body disease. J Neurol Sci 1997; 146: 53-57.